Use of the drug in patients tealoz primary open angle glaucoma syndrome "dry eye"

Dry eye syndrome is frequently observed in patients with primary open-angle glaucoma with prolonged pharmacological hypotensive treatment. Purpose: To analyze the effectiveness Tealoz the drug in patients with primary open-angle glaucoma in the treatment of the syndrome of "dry eye." Materials end Methods: the effectiveness of the drug Tealoz studied in 29 patients with primary open-angle glaucoma (43 eyes) in the treatment of the syndrome of "dry eye." The control group consisted of 34 patients with primary open-angle glaucoma (54 eyes). Results: during treatment Tealoz noted improvement in Schirmer's test values in 23.3% of cases (10 eyes), Norn sample in 18.6% cases (8 eyes), clearance test in 25.6% of cases (11 eyes), LIPCOF test in 16.3% cases (7 eyes). No significant changes in the results of the samples were found in the control group. Conclusions: Tealoz drug effective in the treatment of dry eye syndrome in patients with primary open-angle glaucoma